Keywords: لاکینیمود; Multiple sclerosis; Laquinimod; Gene expression microarray; Peripheral blood mononuclear cells;
مقالات ISI لاکینیمود (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لاکینیمود; Crohn's disease; IL-10 gene-deficient mice; Laquinimod; Intestinal barrier function; NF-κB pathway;
Keywords: لاکینیمود; GBS; Guillain-Barre syndrome; CIDP; chronic inflammatory demyelinating polyneuropathy; AIDP; acute inflammatory demyelinating polyneuropathy; EAN; experimental autoimmune neuritis; EAE; experimental autoimmune encephalomyelitis; PNS; peripheral nervous
Keywords: لاکینیمود; Laquinimod; Neural stem cell; Oligodendrocyte progenitor cell; Multiple sclerosis;
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons
Keywords: لاکینیمود; Laquinimod; Caspase-6; Huntington disease; Bax; YAC128; Neuronal apoptosis;
Nuevos tratamientos para la esclerosis múltiple
Keywords: لاکینیمود; Esclerosis múltiple; Alemtuzumab; Cladribina; Daclizumab; Dalfampridina; Dimetil fumarato; Fingolimod; Laquinimod; Rituximab; TeriflunomidaMultiple sclerosis; Alemtuzumab; Cladribine; Daclizumab; Dalfampridine; Dimethyl fumarate; Fingolimod; Laquinimod; R
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod
Keywords: لاکینیمود; MS oral therapy; Laquinimod; PBMC; Immune measures
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview
Keywords: لاکینیمود; Multiple sclerosis; T- and B-lymphocytes; Fingolimod; Laquinimod; Cladribine; TeriflunomideMS, multiple sclerosis; CNS, central nervous system; RRMS, relapsing remitting MS; PPMS, primary progressive MS; SPMS, secondary progressive MS; PRMS, progressive r
Laquinimod in multiple sclerosis
Keywords: لاکینیمود; Laquinimod;; Multiple sclerosis;; Immune-modulator;; MRI;; Gadolinium enhancing T1 lesion
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
Keywords: لاکینیمود; Autoimmune; B cells; Immunomodulation; Laquinimod; Multiple Sclerosis;
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
Keywords: لاکینیمود; Multiple sclerosis; Experimental autoimmune encephalomyelitis (EAE); T-regulatory cells; Brain derived neurotrophic factor (BDNF); Neuroprotection; Laquinimod;
Oral laquinimod treatment in multiple sclerosis
Keywords: لاکینیمود; Multiple sclerosis; Immunomodulator; Laquinimod; Oral TreatmentsEsclerosis múltiple; Inmunomodulador; Laquinimod; Tratamientos orales
Insight into the mechanism of laquinimod action
Keywords: لاکینیمود; Laquinimod; Axonal damage; Neuroprotection; EAE; Pathology
Promising Emerging Therapies for Multiple Sclerosis
Keywords: لاکینیمود; Alemtuzumab; Daclizumab; BG-12; Fumarate; Cladribine; Fingolimod; Laquinimod; Teriflunomide;
Laquinimod suppress antigen presentation in relapsing–remitting multiple sclerosis: In-vitro high-throughput gene expression study
Keywords: لاکینیمود; Multiple sclerosis; Laquinimod; Microarray gene expression; PBMC; Cell subpopulation
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
Keywords: لاکینیمود; Laquinimod; Acute axonal damage; Cytokines; EAE; Pathology; VLA-4;
Traitements actuels de la SEP
Keywords: لاکینیمود; sclérose en plaques; immunosuppresseurs; immunomodulateurs; interférons β-1; méthylprednisolone; anticorps monoclonaux; fingolimod; laquinimod; tériflunomide; alemtuzumab; daclizumab; rituximab
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-β k.o. and wild type mice
Keywords: لاکینیمود; Laquinimod; chEAE; IFN-β; IFN-β k.o.